tiprankstipranks
Advertisement
Advertisement

Mainz Biomed Receives Nasdaq Notice on Bid Price

Story Highlights
  • On March 20, 2026, Mainz Biomed received notice of noncompliance with Nasdaq’s $1 bid price rule.
  • The company has until September 16, 2026, with possible extension, to restore compliance or risk delisting from Nasdaq.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Mainz Biomed Receives Nasdaq Notice on Bid Price

Meet Samuel – Your Personal Investing Prophet

An announcement from Quantum Cyber ( (QUCY) ) is now available.

On March 20, 2026, Mainz Biomed N.V. disclosed that it had received a notice from Nasdaq’s Listing Qualifications Department stating that the company’s ordinary shares failed to meet the $1.00 minimum bid price requirement for 30 consecutive business days from February 5 to March 19, 2026. The company has been granted a 180-day compliance period, until September 16, 2026, to restore its share price to at least $1.00 for ten consecutive business days, with the possibility of an additional 180 days if it meets other listing criteria and pursues corrective measures such as a reverse stock split.

If Mainz Biomed cannot regain compliance within the available periods or fails to qualify for an extension, its shares could face delisting from Nasdaq, although the company would have the right to appeal any such decision. For now, the notice carries no immediate impact on trading, and the company’s ordinary shares will continue to be listed on the Nasdaq Capital Market as long as it satisfies all other listing requirements.

The most recent analyst rating on (QUCY) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Quantum Cyber stock, see the QUCY Stock Forecast page.

Spark’s Take on QUCY Stock

According to Spark, TipRanks’ AI Analyst, QUCY is a Neutral.

The score is primarily constrained by weak financial performance, including persistent losses, negative operating cash flow, and high leverage. Technicals offer only modest support with short-term improvement but a longer-term downtrend. Valuation impact is neutral due to missing P/E and dividend yield data.

To see Spark’s full report on QUCY stock, click here.

More about Quantum Cyber

Mainz Biomed N.V. operates in the healthcare and life sciences sector, with its ordinary shares listed on the Nasdaq Capital Market. The company’s equity securities are subject to Nasdaq’s continued listing standards, including minimum bid price and market value requirements that govern its access to public capital markets.

Average Trading Volume: 636,313

Technical Sentiment Signal: Sell

Current Market Cap: $6.24M

For detailed information about QUCY stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1